Drug Safety

Kimberton Whole Foods Increases Sales by 42 Percent with Shelf Engine AI

Thursday, April 8, 2021 - 2:00pm

Kimberton Whole Foods has always actively worked to reduce its environmental footprint, but now with Shelf Engine, the company has identified a way to positively impact the planet and also its bottom line.

Key Points: 
  • Kimberton Whole Foods has always actively worked to reduce its environmental footprint, but now with Shelf Engine, the company has identified a way to positively impact the planet and also its bottom line.
  • "Not only has Shelf Engine had an incredible impact on our sales, but these benefits have extended far beyond our shelves," said Robin Brett, Director of Purchasing, Kimberton Whole Foods.
  • Beyond strengthening the customer experience, Shelf Engine offers Kimberton Whole Foods reduced risk and guaranteed upside by buying back any products that don't sell.
  • Using machine learning, Shelf Engine provides grocers with accurate demand forecasts for highly perishable foods, eliminating loss of inventory and out-of-stocks.

New Children's Health Defense/Zogby Strategies Poll finds 32% believe Dr. Anthony Fauci has Pharma's Best Interest at Heart

Monday, April 5, 2021 - 1:00pm

WASHINGTON, April 5, 2021 /PRNewswire/ --In a recent nationwide Zogby online poll, when asked about their viewpoints on Dr. Anthony Fauci, 32% of respondents indicated they believed he had the "pharmaceutical industry's best interest at heart" vs. that of the public.

Key Points: 
  • WASHINGTON, April 5, 2021 /PRNewswire/ --In a recent nationwide Zogby online poll, when asked about their viewpoints on Dr. Anthony Fauci, 32% of respondents indicated they believed he had the "pharmaceutical industry's best interest at heart" vs. that of the public.
  • Among three groups: 18- to 29-year-olds, Hispanics, and Blacks; the percentages regarding the viewpoint that Fauci represents Big Pharma's interests were even higher (41%, 42%, and 38%, respectively).
  • (Note, reports of death to VAERS following vaccination do not necessarily mean the vaccine caused the death.
  • For more information on COVID-19 research and American's rights to not take an Emergency Authorized Use vaccine, visit Children's Health Defense .

Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development

Thursday, April 1, 2021 - 3:42am

Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening.

Key Points: 
  • Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening.
  • In addition to the tests authorized for OTC use, one serial screening test was authorized for use in a point-of-care (POC) setting without a prescription, and an additional screening test was authorized for POC use with a prescription.
  • The addition of the OTC and POC tests for screening will give schools, workplaces, communities and others several options for serial screening tests that are accurate and reliable.
  • These authorizations follow the FDA's recent actions to advance OTC and other screening test development.

Mindset Pharma Expands Scientific Team: Dr. Malik Slassi Appointed Senior VP Innovation and Ian Dean Appointed Director Preclinical Development

Tuesday, March 30, 2021 - 12:00pm

James Lanthier, Chief Executive Officer of Mindset, commented: "We are thrilled to have Dr. Slassi join Mindset on a full-time basis.

Key Points: 
  • James Lanthier, Chief Executive Officer of Mindset, commented: "We are thrilled to have Dr. Slassi join Mindset on a full-time basis.
  • Additionally, Mindset is pleased to welcome Ian Dean as Director, Preclinical Development.
  • Ian is a seasoned toxicologist and pharmacology professional with over 40 years of intensive expertise in drug development.
  • Mr. Dean will assist Mindset in advancing its lead compounds through investigational new drug-enabling studies into clinical programs."

$ 66.51 Million Growth in Global Pharmacovigilance and Drug Safety Software Market 2021-2025 | Evolving Opportunities with Ennov and EXTEDO GmbH | Technavio

Tuesday, March 30, 2021 - 12:30am

The pharmacovigilance and drug safety software market is driven by increasing approvals of new molecules and biosimilars.

Key Points: 
  • The pharmacovigilance and drug safety software market is driven by increasing approvals of new molecules and biosimilars.
  • In addition, the rising incidence rates of adverse drug events are anticipated to boost the growth of the pharmacovigilance and drug safety software market.
  • This has necessitated the need for effective drug monitoring solutions such as pharmacovigilance and drug safety software.
  • Pharmacovigilance and Drug Safety Software Market End-user Outlook (Revenue, USD mn, 2020-2025)
    Pharmacovigilance and Drug Safety Software Market GeographicOutlook (Revenue, USD mn, 2020-2025)
    Are you a start-up willing to make it big in the business?

CPHO Sunday Edition: Vaccine safety in Canada: What you should know

Sunday, March 28, 2021 - 8:04pm

I know that many of you are curious to know more about vaccine safety and how adverse events following immunization (AEFIs) are monitored in Canada.

Key Points: 
  • I know that many of you are curious to know more about vaccine safety and how adverse events following immunization (AEFIs) are monitored in Canada.
  • Canada has a strong vaccine safety monitoring system that remains in place for as long as the vaccine is used.
  • The Canadian Vaccine Safety Network (CANVAS) is a national network of sites across Canada that conducts vaccine safety surveillance during implementation of immunization campaigns.
  • In the case of COVID-19 vaccine monitoring, we are seeing even greater international collaboration and communication on vaccine safety.

Therma Bright Receives IRB Approval and Submits Application to Health Canada to Begin Clinical Study for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Thursday, March 25, 2021 - 12:00pm

Therma's clinical research organization prepared and filed the necessary documentation for the IRB and Health Canada submissions.

Key Points: 
  • Therma's clinical research organization prepared and filed the necessary documentation for the IRB and Health Canada submissions.
  • They are now focused on readying the trial site and personnel to begin the study once the Health Canada go ahead is received.
  • Rob Fia, CEO, commented, "This is yet another significant milestone in moving our AcuVid test closer to market.
  • Last week, the US FDA announced new guidance to streamline the approval and use of rapid Covid-19 tests in the US.

Facebook Canada works with the Government of Canada to help reach millions of Canadians with COVID-19 vaccine information

Tuesday, March 23, 2021 - 8:00am

TORONTO, March 23, 2021 /CNW/ - Working with the Government of Canada, today Facebook Canada is launching a number of initiatives to support Canadian health authorities' efforts to reach millions of Canadians with trusted COVID-19 vaccine information.

Key Points: 
  • TORONTO, March 23, 2021 /CNW/ - Working with the Government of Canada, today Facebook Canada is launching a number of initiatives to support Canadian health authorities' efforts to reach millions of Canadians with trusted COVID-19 vaccine information.
  • "The Public Health Agency is committed to providing Canadians with accurate information on vaccine safety and effectiveness.
  • I know that Canadians also discuss and share health information they receive from friends, family and community leaders.
  • Facebook is a registered trademark of Facebook Inc. All other brand or product names mentioned may be trademarks or registered trademarks of their respective holders.

Trevi Therapeutics to Report Q4 and Year End 2020 Financial Results on March 25

Thursday, March 18, 2021 - 8:05pm

ET on March 25, 2021, to provide a corporate update and review the Companys financial results for the quarter and year ended December 31, 2020.

Key Points: 
  • ET on March 25, 2021, to provide a corporate update and review the Companys financial results for the quarter and year ended December 31, 2020.
  • To participate in the live conference call by phone, please dial (866) 360-5746 (domestic) or (602) 563-8605 (international) and provide access code 8599904.
  • An archived replay of the webcast will also be available for 30 days on the Companys website following the event.
  • Haduvio is an investigational drug product and its safety and efficacy have not been fully evaluated by any regulatory authority.

Cano Health Announces COVID-19 Vaccination Efforts for its Highest-Risk, Elderly Patients

Thursday, March 18, 2021 - 12:00pm

As more supply becomes available, Cano Health hopes to expand its program to eligible people in the communities served by its 60+ medical centers in Florida.

Key Points: 
  • As more supply becomes available, Cano Health hopes to expand its program to eligible people in the communities served by its 60+ medical centers in Florida.
  • Cano Health is part of a State of Florida pilot program that aims to distribute COVID-19 vaccines directly to primary care physician offices where elderly patients receive routine care.
  • "I am highly appreciative of state officials for including Cano Health in this critical initiative," said Dr. Marlow Hernandez, Founder and CEO of Cano Health.
  • Cano Health has already vaccinated thousands of its patients and continues to contact its highest-risk patients to schedule appointments and transportation to those medical centers prepared to administer the vaccine.